LGNDZ Earnings
Ligand Pharmaceuticals, Inc.
1W: +19.8%
1M: +42.2%
3M: -77.7%
YTD: -66.5%
$0.00
+0.00 (+33.88%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Last Earnings
2022-11-08
EPS
$0.02
▲ Beat +0.0%
Revenue
$66M
▲ Beat +0.0%
Next Earnings
2026-11-05
EPS Estimate
$2.99
Range: $2.68 - $3.30
Revenue Estimate
$97M
1 analysts
Estimate vs Actual
Earnings Surprise History
0/1
EPS Beats
0/1
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | annual | 2027-12-31 | $12.16 | $12.11 | ▼ 0.05 | $385,279,798 | $385,279,798 |
| 2026-09-28 | annual | 2026-12-31 | $9.30 | $9.31 | ▲ 0.01 | $290,351,350 | $290,351,350 |
| 2026-09-28 | annual | 2028-12-31 | $14.62 | $14.58 | ▼ 0.04 | $458,139,422 | $458,139,422 |
| 2026-09-25 | annual | 2027-12-31 | $12.13 | $12.16 | ▲ 0.03 | $384,454,798 | $385,279,798 |
| 2026-09-25 | annual | 2028-12-31 | $14.58 | $14.62 | ▲ 0.04 | $456,719,422 | $458,139,422 |
| 2026-09-25 | quarter | 2026-09-30 | $2.30 | $2.31 | ▲ 0.01 | $78,092,992 | $77,948,548 |
| 2026-09-25 | annual | 2029-12-31 | $16.36 | $16.43 | ▲ 0.07 | $551,405,333 | $553,672,000 |
| 2026-09-25 | annual | 2026-12-31 | $9.32 | $9.30 | ▼ 0.02 | $290,618,017 | $290,351,350 |
| 2026-09-25 | quarter | 2027-12-30 | $3.36 | $3.49 | ▲ 0.13 | $100,081,000 | $100,081,000 |
| 2026-09-25 | quarter | 2027-09-30 | $2.98 | $3.04 | ▲ 0.06 | $90,697,000 | $90,697,000 |
| 2026-09-25 | quarter | 2027-06-30 | $2.70 | $2.71 | — | $85,688,000 | $85,688,000 |
| 2026-09-25 | quarter | 2026-12-30 | $3.01 | $2.99 | ▼ 0.02 | $97,396,802 | $97,274,580 |
| 2026-09-25 | annual | 2030-12-31 | $19.14 | $19.20 | ▲ 0.06 | $668,311,667 | $670,411,667 |
| 2026-09-23 | quarter | 2026-12-30 | $3.01 | $3.01 | — | $97,354,136 | $97,396,802 |
| 2026-09-23 | annual | 2028-12-31 | $14.54 | $14.58 | ▲ 0.04 | $455,759,422 | $456,719,422 |
Earnings Call Transcripts
No transcripts available.